Clinical Trial Update: The PROMISE Study: Duavee in Women With DCIS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the PROMISE Study evaluating Duavee (bazedoxifene/conjugated estrogens) in postmenopausal women with ductal carcinoma in situ …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ

Drugs mentioned

• Duavee (bazedoxifene/conjugated estrogens)

Snippet

Sponsor: Northwestern University | Conditions: Ductal Breast Carcinoma In Situ, Postmenopausal | Phase 2 | Status: COMPLETED